| |
Early group
|
Delayed group
|
---|
Morning
|
Noon
|
Evening
|
Morning
|
Noon
|
Evening
|
---|
Phase 1
|
Week 1 (capsules)
|
50/12.5
|
Placebo
|
50/12.5
|
Placebo
|
Placebo
|
Placebo
|
Week 2 (capsules)
|
100/25
|
50/12.5
|
50/12.5
|
Placebo
|
Placebo
|
Placebo
|
Weeks 3 to 40 (tablets)
|
100/25
|
100/25
|
100/25
|
Placebo
|
Placebo
|
Placebo
|
Phase 2
|
Week 41 (capsules)
|
100/25
|
100/25
|
100/25
|
50/12.5
|
Placebo
|
50/12.5
|
Week 42 (capsules)
|
100/25
|
100/25
|
100/25
|
100/25
|
50/12.5
|
50/12.5
|
Week 43 to 80 (tablets)
|
100/25
|
100/25
|
100/25
|
100/25
|
100/25
|
100/25
|
- Doses are written as levodopa/carbidopa milligram